A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

A Randomized, Double-blind, Active-controlled, Multi-center, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combined Administration of AD-2281 and AD-2282 in Patients with Primary Hypercholesterolemia.

The purpose of this study is to evaluate the efficacy and safetyof co-administration of AD-2281 and AD-2282 in patients with Primary Hypercholesterolemia

Inclusion Criteria:

• Signed informed consent
• Patients with Primary Hypercholesterolemia
• Other inclusions applied

Exclusion Criteria:

• Patients with Secondary Hypercholesterolemia
• Other exclusions applied